Nektar Therapeutics Reports First Quarter 2026 Financial Results
Go back to Nektar Therapeutics Reports First Quarter 2026 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 66.07 +5.09 (8.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.98 | 52 Week High | $19.98 | |||
| Open | $62.30 | 52 Week Low | $10.52 | |||
| Day High | $66.60 | P/E | N/A | |||
| Day Low | $62.30 | EPS | $-1.45 | |||
| Volume | 620,294 | |||||

